Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

New research reveals that years of firefighting may leave a deadly genetic mark, as toxic chemicals used on the job are now linked to brain cancer-causing mutations. Study: Glioma mutational ...

Together, we intend to accelerate the field of next-generation medicines in mRNA and CRISPR, using best-in-class chemistries, processes, and proprietary technologies like CleanCap ® analogs ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

Forbes contributors publish independent expert analyses and insights.

We’ll primarily focus on the dose-expansion part. The phase 2 trial was focused on ROS1- positive NSCLC. There were also other cohorts for patients with nonlung cancer with ROS1 fusion. ROS1 can ...

After hours: March 21 at 7:58:23 PM EDT Loading Chart for MRNA ...